Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination With Prednisolone Versus Prednisolone Alone in Subjects With Severe Alcoholic Hepatitis (AH)

NCT02854631 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02854631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02854631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination With Prednisolone Versus Prednisolone Alone in Subjects With Severe Alcoholic Hepatitis (AH)
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2016
Completion date
May 31, 2018
Enrollment
104 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis (ah)